Published DateClear

Start Date

End Date

Category

• Business1
• Pipeline1

Organizations

• Bausch + Lomb76
• Eyes On Eyecare58
• Alcon, Inc.52
• American Optometric Association42
• Harrow35
• Glaukos31
• Topcon Healthcare26
• Regeneron25
• Coopervision23
• Aldeyra Therapeutics21

Tags

• Clinical Trials2
• Acquisitions1
• Cataract1
• Eye Drop Solution1
• Eye Drops1
• Research1
• Retina1

• Organizations: Lexitas Pharma Services✕

Clear all

Pipeline

Lexitas, Ocusun dose first patient in pilot study for age-related cataract eye drop

Derived from a naturally-occurring steroid molecule, ZOC2017217 is a potential alternative treatment that could reshape the landscape of cataract care.

Business

Lexitas acquires Erie Retina Research to expand ophthalmic trials

Partnership also involves integration of CASExERIE and Element Erie: Imaging and Reading Center to establish a fully integrated retina research platform.